Sonnet BioTherapeutics Holdings Insider Trades

SONN

Track insider trading activity from Sonnet BioTherapeutics Holdings executives and directors. See which insiders are buying and selling SONN stock.

Trades Last 12 Months

All Insider Trades for Sonnet BioTherapeutics Holdings

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mcandrew Stephen J Chief Business Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.12k 6,446 shares
$1.26
$1.26
Bhatt Nailesh Director
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.3k 10,547 shares
$1.26
$1.26
Cini John K. Director
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$17.8k 14,116 shares
$1.26
$1.26
Dexter Susan Director
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$12.2k 9,643 shares
$1.26
$1.26
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.72k 4,537 shares
$1.26
$1.26
Griffith Donald J. Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.1k 10,375 shares
$1.26
$1.26
Rao Raghu Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$28.2k 22,356 shares
$1.26
$1.26
Kenney Richard T Chief Medical Officer
Holding Value $206k 163,760 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 250,265 shares
$1.26
$1.26
Mc Neill Lori Director
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.54k 4,394 shares
$1.26
$1.26
Mcneill Lori Director
Holding Value $5.54k 4,394 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.7k 4,000 shares
$5.17
$1.26
Cross John Harry Iii Chief Financial Officer
Holding Value $2k 1,588 shares
Last Trade
Dec 11, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.8k 1,452 shares
$11.59
$1.26
Mohan Pankaj Chairman, President And CEO
Holding Value $18.9k 14,987 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.6k 7,554 shares
$11.59
$1.26
Rugg Terence Anthony Chief Medical Officer
Holding Value $26.9k 21,314 shares
Last Trade
Jul 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190M 21,314 shares
$8,935.38
$1.26
Pruitt Michael D Ceo, Chairman
Holding Value $44.7k 35,462 shares
Last Trade
Mar 23, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$219M 7,000 shares
$31,328.61
$1.26
Glick Frederick L President
Holding Value $5.04k 4,000 shares
Last Trade
Mar 23, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$157M 5,000 shares
$31,328.61
$1.26
Holding Value $0 0 shares
Last Trade
Nov 21, 2019 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$17.2B 400,000 shares
$42,964.95
$1.26
Wagoner J Eric Director
Holding Value $24.6k 19,561 shares
Last Trade
Jun 24, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$320M 5,000 shares
$63,935.94
$1.26
Harkleroad Patrick Clay Chief Financial Officer
Holding Value $12.6k 10,000 shares
Last Trade
Apr 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$953M 10,000 shares
$95,264.54
$1.26
Kiefer Neil G Director
Holding Value $26.8k 21,304 shares
Last Trade
Apr 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84B 19,304 shares
$95,264.54
$1.26
Holding Value $21.7k 17,246 shares
Last Trade
Apr 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.43B 15,000 shares
$95,264.54
$1.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up